Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Mon Mar 31 18:47:24 GMT 2025
by
admin
on
Mon Mar 31 18:47:24 GMT 2025
|
| Source Materials Class | ORGANISM |
| Source Materials Type | HUMAN |
| Source Materials Parent | |
| Part | blood |
| Fraction Material Type | cell |
| Fraction Name | erythrocyte |
| Record UNII |
2K524Y8G0J
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 640.16
Created by
admin on Mon Mar 31 18:47:24 GMT 2025 , Edited by admin on Mon Mar 31 18:47:24 GMT 2025
|
||
|
CFR |
21 CFR 640.17
Created by
admin on Mon Mar 31 18:47:24 GMT 2025 , Edited by admin on Mon Mar 31 18:47:24 GMT 2025
|
||
|
CFR |
21 CFR 640.11
Created by
admin on Mon Mar 31 18:47:24 GMT 2025 , Edited by admin on Mon Mar 31 18:47:24 GMT 2025
|
||
|
CFR |
21 CFR 640.10
Created by
admin on Mon Mar 31 18:47:24 GMT 2025 , Edited by admin on Mon Mar 31 18:47:24 GMT 2025
|
||
|
FDA ORPHAN DRUG |
370712
Created by
admin on Mon Mar 31 18:47:24 GMT 2025 , Edited by admin on Mon Mar 31 18:47:24 GMT 2025
|
||
|
CFR |
21 CFR 640.14
Created by
admin on Mon Mar 31 18:47:24 GMT 2025 , Edited by admin on Mon Mar 31 18:47:24 GMT 2025
|
||
|
CFR |
21 CFR 640.12
Created by
admin on Mon Mar 31 18:47:24 GMT 2025 , Edited by admin on Mon Mar 31 18:47:24 GMT 2025
|
||
|
WHO-ATC |
B05AX01
Created by
admin on Mon Mar 31 18:47:24 GMT 2025 , Edited by admin on Mon Mar 31 18:47:24 GMT 2025
|
||
|
CFR |
21 CFR 640.13
Created by
admin on Mon Mar 31 18:47:24 GMT 2025 , Edited by admin on Mon Mar 31 18:47:24 GMT 2025
|
||
|
CFR |
21 CFR 640.15
Created by
admin on Mon Mar 31 18:47:24 GMT 2025 , Edited by admin on Mon Mar 31 18:47:24 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000089120
Created by
admin on Mon Mar 31 18:47:24 GMT 2025 , Edited by admin on Mon Mar 31 18:47:24 GMT 2025
|
PRIMARY | |||
|
SUB15114MIG
Created by
admin on Mon Mar 31 18:47:24 GMT 2025 , Edited by admin on Mon Mar 31 18:47:24 GMT 2025
|
PRIMARY | |||
|
CHEMBL2108195
Created by
admin on Mon Mar 31 18:47:24 GMT 2025 , Edited by admin on Mon Mar 31 18:47:24 GMT 2025
|
PRIMARY | |||
|
2K524Y8G0J
Created by
admin on Mon Mar 31 18:47:24 GMT 2025 , Edited by admin on Mon Mar 31 18:47:24 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
LIGAND->BINDER |
Distributed preferentially into the red cell fraction inblood with most extensive distribution into human red cells
|
